LANXESS signs contract to acquire Chemtura

Specialty chemicals company LANXESS has signed a contract to take over the US-based specialty chemicals company Chemtura Corporation. Chemtura is one of the major global providers of high-quality flame retardant- and lubricant additives. LANXESS is offering all cash consideration of USD 33.50 per share.

For the transaction with an enterprise value of around EUR 2.4 billion LANXESS has secured bridge financing. The bridge financing will quickly be refinanced via senior bonds and a hybrid bond. Furthermore, LANXESS will use existing liquidity for financing.

Closing is subject to approval by Chemtura shareholders, any required regulatory approvals and certain other customary closing conditions. Closing of the transaction is anticipated mid-2017.

Chemtura employs worldwide approximately 2,500 employees and has 20 sites in 11 countries. The company’s headquarters are in Philadelphia, Pennsylvania. The stock market listed company reported sales of around EUR 1.5 billion in the last four quarters and EBITDA pre exceptionals of approximately EUR 245 million. Around 45 percent of its turnover are generated in North America. In addition to additives, the portfolio also comprised urethanes and organometallics.

A combination of both companies would materially expand LANXESS’ business activities in additives for lubricants and flame retardants.

Against the backdrop of the acquisition, the announced share buy-back of around EUR 200 million will not be pursued further.

MORE ABOUT THIS TOPIC

AD HOC

LANXESS signs contract to sell Urethane Systems business for an enterprise value of €460 m to UBE Corporation - proceeds will be used to reduce net financial debt

October 03, 2024
AD HOC

LANXESS: EBITDA pre exceptionals for second quarter 2024 significantly above market expectation

July 17, 2024
AD HOC

Impairment of goodwill and adjustment of at-equity book value of minority interest in Envalior

February 27, 2024
AD HOC

LANXESS adjusts expectations FY 2023; Board of Management proposes dividend reduction

November 06, 2023
AD HOC

LANXESS: Results for Q2 and FY 2023 estimated below market expectations

June 19, 2023